Iobst Stacey E, Novak Priscilla, Ali Mir M
J Obstet Gynecol Neonatal Nurs. 2024 Jul;53(4):355-367. doi: 10.1016/j.jogn.2024.01.004. Epub 2024 Feb 2.
To examine use of mental health treatment, substance use disorder treatment, and perceived barriers to treatment by whether a major depressive episode occurred during the past year among parenting women with opioid use disorder.
Secondary analysis of survey data from the National Survey on Drug Use and Health, 2015-2019.
United States.
Women aged 18 to 44 years with opioid use disorder and at least one child in the household.
We computed descriptive statistics for demographic characteristics, treatment by major depressive episode status, and barriers to treatment by major depressive episode status. We conducted multinomial logistic regression to examine associations among demographic characteristics, major depressive episode status, and type of treatment.
Of the 36% of respondents in our weighted sample (N ≈ 254,300) who experienced major depressive episode, 35% received substance use disorder and mental health treatment, and 27% did not receive any form of treatment. We found that identification as a person of color was significantly associated with a lower relative risk of receiving any type of treatment. Frequently reported barriers to treatment included affordability, access, and stigma.
Respondents with opioid use disorder and co-occurring major depressive episode did not obtain necessary treatment. Barriers to treatment, including affordability, access to treatment, and stigma, need to be addressed, particularly among women of color.
